Role of hepatitis C virus in dual and triple hepatitis virus infection
Related Experiment Video
Updated: Oct 9, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
1Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung Medical College, Taipei, Taiwan.
Insights
Hepatitis C virus (HCV) coinfection with Hepatitis B virus (HBV) or Hepatitis D virus (HDV) often leads to severe liver disease. HCV can suppress HBV and HDV, highlighting the need for monitoring coinfected patients.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) share transmission routes, leading to potential co-infections.
- HCV assays have advanced, necessitating a review of HCV's role in multiple hepatotropic viral infections.
Purpose of the Study:
- To review and evaluate the clinical and virological significance of HCV in patients with multiple hepatotropic viral infections.
- To understand the complex interactions and impact of HCV in co-infections.
Main Methods:
- Literature review of seroprevalence studies.
- Analysis of clinical and virological data from patients with single and multiple hepatitis virus infections.
Main Results:
- HCV is found in over 10% of HBV- or HDV-infected patients globally.
- Dual or triple infections with HCV often result in severe, interferon-resistant liver disease.
- HCV demonstrates a suppressive effect on HBV and HDV, potentially leading to seroclearance of HBV antigens.
Conclusions:
- Co-infection with HCV necessitates vigilant monitoring in patients with HBV or HDV infections.
- The complex viral dynamics and suppressive impact of HCV in co-infections require further investigation.
- HCV assays are crucial for clinical studies involving multiple hepatotropic viral infections.
Abstract:
Hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) share same transmission routes, thus dual or triple infection may occur and even persist in the same patients. A significant amount of literature has accumulated since the advent of HCV assays. It is pertinent to review and evaluate the clinical and virological significance of HCV in multiple hepatotropic viral infection. The reported series on seroprevalence of HCV indicate that HCV is found in more than 10% of HBV- or HDV-infected patients worldwide. Of the patients with dual or triple infection involving HCV, those having coreplication of viruses tend to have severe and progressive liver disease that is resistant to interferon therapy, in contrast with patients having a single virus infection. Paradoxically, dual or triple hepatitis virus infections are associated with viral interference. In particular, HCV exerts a suppressive effect on HBV and HDV and may enhance seroclearance of HBV antigens or even usurp the role of preexisting virus as the agent for continuing hepatitis. Although HBV and HDV may also suppress HCV, it appears to be less effective. These findings clearly suggest the necessity of monitoring patients with HBV or HDV infections. In view of complex dynamism of viral interaction in multiple hepatotropic virus infection, the importance of HCV assay in the clinical studies can not be overemphasized. The basic mechanisms that regulate the viral interactions, in particular the impact of HCV in dual or triple virus infections, remain to be investigated.
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Cytomegalovirus Disease
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

